Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0380
-0.0010 (-2.56%)
May 29, 2026, 4:10 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 136.47 million as of May 29, 2026. Its market cap has increased by 95.24% in one year.
Market Cap
136.47M
Enterprise Value
130.16M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 136.47M, an increase of 951.97%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 136.47M | -29.80% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 208.27M |
| Recce Pharmaceuticals | 159.05M |
| Nyrada | 122.47M |
| Island Pharmaceuticals | 112.45M |
| Dimerix | 111.07M |
| Alterity Therapeutics | 97.88M |
| Paradigm Biopharmaceuticals | 86.70M |
| Arovella Therapeutics | 85.82M |